跳至主要内容
临床试验/NL-OMON26348
NL-OMON26348已完成不适用

Improving the efficiency and quality of follow-up after curative treatment for breast cancer.

Prof.dr. Ph. Lambin, MAASTRO clinic, Dr. Tanslaan 12, 6229 ET Maastricht0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
320

研究概览

简要总结

  1. Kimman ML, Voogd AC, Dirksen CD, Falger P, Hupperets P, Keymeulen K, Hebly M, Dehing C, Lambin Ph, Boersma LJ. Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits? Eur J Cancer 43: 647-653, 2007.
    2. Kimman ML, Voogd AC, Dirksen CD, Falger P, Hupperets P, Keymeulen K, Hebly M, Dehing C, Lambin Ph, Boersma LJ. Improving the quality and efficiency of follow-up after curative treatment for breast cancer - rationale and study design of the MaCare trial. BMC Cancer 7:1, 2007.
    3. Kimman ML, Dirksen CD, Lambin Ph, Boersma LJ. Responsiveness of the EQ-5D compared to the EORTC QLQ-C30 in primary breast cancer patients after treatment. BMC Health and Quality of Life Outcomes 7:11, 2009.
    4. Kimman ML Bloebaum MMF, Dirksen CD, Houben RMA, Lambin P, Boersma LJ Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer 30;10:174, 2010.
    5. Kimman ML¹, Dirksen CD, Voogd AC, Falger P, Gijsen BCM, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JKS, van Riet Y, Brenninkmeijer SJ, Scheijmans L, Kessels A, Lambin Ph, Boersma LJ Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2x2 randomised controlled trial. Eur J Cancer, 47(7):1027-36, 2011.
    6. Kimman ML, Dirksen CD, Voogd AC Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ.An economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer 47(8):1175-85, 2011.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female patients with breast cancer without distant metastases;
  • 2. WHO performance scale 0-2;

排除标准

  • Not fulfilling the inclusion criteria.

研究者

发起方
Prof.dr. Ph. Lambin, MAASTRO clinic, Dr. Tanslaan 12, 6229 ET Maastricht

相似试验